מדינה: הולנד
שפה: אנגלית
מקור: HMA (Heads of Medicines Agencies)
altrenogest 4 mg
Virbac S.A.
QG03DX90
Oral solution
Altrenogest
Pigs
2009-05-27
Revised: December 2012 AN. 01534/2011 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT VIRBAGEST 4 mg/ml oral solution for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Altrenogest 4.00 mg/ml EXCIPIENTS: Butylhydroxytoluene (E321) 0.07 mg/ml Butylhydroxyanisole (E320) 0.07 mg/ml For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral solution for top-dressing use. Clear, slightly yellow solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs (nulliparous mature sows). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the synchronisation of oestrus in nulliparous mature sows. 4.3 CONTRAINDICATIONS Do not use in boars. Do not administer to pregnant sows (see section 4.7) or those suffering from uterine infection. Do not use in case of hypersensitivity to the active substance. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Revised: December 2012 AN. 01534/2011 Page 2 of 5 Ensure the correct dose is administered daily as under dosing can lead to the formation of cystic follicles. Add the veterinary medicinal product to the feed immediately before feeding. Discard any uneaten medicated feed. Use only in sexually mature gilts that have been in oestrus. Part consumed feed must be safely disposed of and not given to any other animal. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Women who are pregnant, or קרא את המסמך השלם